期刊文献+

HACCP认证法用于化疗药物配置的职业防护安全管理 被引量:4

The usage of hazard analysis critical control point(HACCP) in occupational protection and safety control of chemotherapeutics compounding
下载PDF
导出
摘要 研究表明多数抗癌药为细胞毒制剂,具有毒性、致畸性、致突变性和致癌性等特点。目前国内有越来越多的医院意识到此危害并已着手建立了静脉药物配置中心,配有生物安全柜,实行了化疗药物的集中配置与管理。本院运用HACCP认证法(即危害分析与关键控制点),将预防性的理念应用于化疗药物职业防护中,从环节关键点上控制化疗药物的安全配置。根据化疗药物使用要求,提前分析危害,找出问题控制的关键点,确定安全的监控方法,进行预防干预。本文就如何运用HACCP认证法(即危害分析与关键控制点),将预防性的理念应用于化疗药物职业防护预防等方面进行探讨。 Research shows that most of cytotoxic agents for cancer drug, they have the characteristic such as toxic, teratogenic sex and the axonal degeneration and carcinogenicity. At present there are more and more hospitals recognizing the harm and setting up a file to establish the pivas in our country, equipped with biological safety cabinet, have implemented the chemotherapy drug concentration allocation and management. Our hospital use hazard analysis critical control point (HACCP) attestation method (namely the hazard analysis and critical control point), pay preventive concept for chemotherapy drugs in occupational protection, the key point control the link from chemotherapy drugs with safety. According to the chemotherapy drug use requirement, analysis the hazard early, find out the problems of the control key points, determine the safety monitoring method to prevent intervention. This paper will be discussed how to use HACCP attestation method (namely the hazard analysis and critical control point), discuss preventive concept for the chemotherapy drug prevention of occupational protection discussed in this paper.
出处 《中国当代医药》 2011年第36期147-148,共2页 China Modern Medicine
关键词 HACCP认证法 化疗药物配置 职业防护安全 管理 Hazard analysis critical control point authentication method Chemotherapy compounding Occupational protective safety Management
  • 相关文献

参考文献4

二级参考文献9

共引文献12

同被引文献49

  • 1卫生部卫生法制与监督司,中国疾病预防控制中心职业卫生与中毒控制所.建设项目职业病危害评价[M].北京:中国人13出版社,2003:65-78.
  • 2Cartwright TH.Adverse events associated with antiangio- genie agents in combination with cytotoxic chemotherapy in metastatic co]orectal cancer and their management[J]. Clin Colorectal Cancer,2013,12(2):86-94.
  • 3Lambert JM.Drug-conjugated antibodies for the treatment of caneer[J].Br J Clin Pharmacol,2013,76(2) :248-262.
  • 4Tosti G, Cocorocehio E, Pennaechioli E.Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma[J].Clin Cos- met Investig Dermatol, 2013,6 : 245-256.
  • 5Zhong Y, Shuzheng M, Yingge Z.Using activated carbon nanoparticles to decrease the genotoxicity and teratogenic- ity of anticancer therapeutic agents[J].J Nanosci Nanotech- nol,2010,10(12) :8603-8609.
  • 6王春燕,李文静.医务人员对化疗药物的自身防护[J].中国实用护理杂志,2012,7(28):241-242.
  • 7中华人民共和国卫生部.工业企业设计卫生标准:GBZ1-2010[S].北京:人民卫生出版社,2010:1-21.
  • 8中华人民共和国卫生部.建设项目职业病危害控制效果评价技术导则:GBZ/T197-2007[S].北京:人民卫生出版社,2008:1-16.
  • 9中华人民共和国卫生部.工作场所防止职业中毒卫生工程防护措施规范:GBZ/T 194-2007[S].北京:人民卫生出版社,2008:1-13.
  • 10ROSAS P,REYES G.Design of a HACCP plan for the industrial process of frozen sardines[J].Arch Latinoam Nutr,2009,59(3):310-317.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部